0001140361-17-042167.txt : 20171113 0001140361-17-042167.hdr.sgml : 20171110 20171113165135 ACCESSION NUMBER: 0001140361-17-042167 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171110 FILED AS OF DATE: 20171113 DATE AS OF CHANGE: 20171113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hartman Thomas E CENTRAL INDEX KEY: 0001466989 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 171196693 MAIL ADDRESS: STREET 1: HANGER ORTHOPEDIC GROUP, INC. STREET 2: TWO BETHESDA METRO CENTER, SUITE 1200 CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0306 4 2017-11-10 0 0000722723 HANGER, INC. HGR 0001466989 Hartman Thomas E 10910 DOMAIN DRIVE SUITE 300 AUSTIN TX 78758 0 1 0 0 SVP and General Counsel Common Stock 2017-11-10 4 F 0 340 11.56 D 38560 D Stock Options (right to buy) 12.77 2027-05-19 Common Stock 70818 70818 D Performance Share Units 2020-05-19 Common Stock 28327 28327 D Reflects payment of tax liability by withholding shares of stock incident to vesting of restricted stock previously issued. Consists of (i) unvested restricted shares which total 10,000 shares of stock from an initial grant of 10,000 shares of restricted stock that begins to vest on March 8, 2018; (ii) unvested restricted shares and fully vested shares totaling 4,658 shares of stock from an initial grant of 5,000 shares of restricted stock that begins to vest on October 11, 2017; (iii) unvested restricted shares and fully vested shares totaling 9,338 shares of stock from an initial grant of 10,000 shares of restricted stock that begins to vest on March 7, 2017; (iv) unvested restricted shares and fully vested shares totaling 4,279 shares of stock from an initial grant of 4,958 shares of restricted stock made on November 10, 2015; (v) unvested restricted shares and fully vested shares totaling 3,958 shares of stock from an initial grant of 4,239 shares of restricted stock made on March 6, 2015; [continued in next footnote] (vi) unvested restricted shares and fully vested shares totaling 1,474 shares of stock from an initial grant of 1,731 shares of restricted stock made on March 7, 2014; (vii) unvested restricted shares and fully vested shares totaling 2,000 shares of stock from an initial grant of 3,246 shares of restricted stock and performance made on March 11, 2013; (viii) fully vested shares totaling 2,008 shares from an initial grant of 4,800 shares of restricted stock made on March 7, 2012 and (ix) fully vested shares totaling 845 shares from an initial grant of 4,600 shares of restricted stock made on March 25, 2011 and cumulatively vest to the extent of one-quarter each year thereafter, subject to certain provisions under the Company's 2010 Omnibus Incentive Plan and the Plan, and which shall become fully vested upon a termination of employment not involving termination for cause or voluntary termination. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020. Performance share units ("PSUs") were granted under the Company's Special Equity Plan. Each PSU represents a contingent right to receive one share of common stock if predetermined levels of absolute common stock price compounded annual growth rate are achieved over a three-year performance period ending on the third anniversary of the grant date. The number of PSUs shown in the table represents the maximum number that could be earned; the target number is one-half the maximum number. /s/ Jessica Lochmann Allen, Attorney-in-Fact for Thomas E. Hartman 2017-11-13